Cartesian Growth Corporation II Unit
RENEU
RENEU was delisted on the 19th of February, 2025.
15 hedge funds and large institutions have $23.9M invested in Cartesian Growth Corporation II Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 4 closing their positions.
17% less funds holding
Funds holding: 18 → 15 (-3)
58% less capital invested
Capital invested by funds: $57.6M → $23.9M (-$33.6M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
-$15.1M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$8.02M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$5.52M |
| 4 |
AC
Athos Capital
Hong Kong
|
-$4.01M |
| 5 |
WC
Wealthspring Capital
West Harrison,
New York
|
-$2.05M |
RENEU Hedge Fund Activity: Q4 2022 in Review
15 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Cartesian Growth Corporation II Unit (RENEU) for Q4 2022, worth a combined $23.9M — down 58% from $57.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RENEU and 1 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 0 added.
The largest seller was Calamos Advisors, exiting entirely with an estimated $15.1M sold.
- 15 institutional investors held Cartesian Growth Corporation II Unit (RENEU) as of Q4 2022, down from 18 in Q3 2022.
- Funds reported $23.9M of Cartesian Growth Corporation II Unit stock for Q4 2022, down 58% quarter-over-quarter.
- 1 fund opened new Cartesian Growth Corporation II Unit positions in Q4 2022 and 4 closed out, a net change of -3 holders.
- The largest Cartesian Growth Corporation II Unit seller in Q4 2022 was Calamos Advisors, an estimated $15.1M sold.
Based on aggregated 13F filings for Q4 2022.